Gene: AP4B1
Official Full Name: adaptor related protein complex 4 subunit beta 1provided by HGNC
Gene Summary: This gene encodes a subunit of a heterotetrameric adapter-like complex 4 that is involved in targeting proteins from the trans-Golgi network to the endosomal-lysosomal system. Mutations in this gene are associated with cerebral palsy spastic quadriplegic type 5 (CPSQ5) disorder. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31600 | AP4B1 Knockout cell line (HeLa) | Human | AP4B1 | 1:3~1:6 | Negative | Online Inquiry |
KO31601 | AP4B1 Knockout cell line (HCT 116) | Human | AP4B1 | 1:2~1:4 | Negative | Online Inquiry |
KO31602 | AP4B1 Knockout cell line (HEK293) | Human | AP4B1 | 1:3~1:6 | Negative | Online Inquiry |
KO31603 | AP4B1 Knockout cell line (A549) | Human | AP4B1 | 1:3~1:4 | Negative | Online Inquiry |
AP4B1 Gene Knockout Cell Lines represent an innovative advancement in genetic research, designed specifically to facilitate the study of the AP4B1 gene's function and its associated biological pathways. These genetically modified cell lines have been engineered to completely disrupt the expression of the AP4B1 gene, a vital component in the clathrin-mediated endocytic pathway, which plays a critical role in intracellular transport and cellular signaling.
The primary mechanism involves the use of CRISPR-Cas9 technology to induce targeted double-strand breaks in the AP4B1 gene's DNA, leading to frameshift mutations that result in a complete knockout of functional protein expression. This allows researchers to elucidate the functional roles of AP4B1 in cellular dynamics, protein sorting, and its implications in various diseases, including certain neurodegenerative disorders and cancers.
The scientific importance of AP4B1 Gene Knockout Cell Lines in research is profound. They serve as essential tools in studying gene function, validating gene-targeting methodologies, and investigating the molecular mechanisms underlying diseases. In clinical settings, these cell lines can facilitate drug screening, biomarker identification, and the development of gene therapies aimed at restoring normal AP4B1 function.
What sets these cell lines apart from alternatives is their high specificity and reproducibility, coupled with the ease of use associated with CRISPR technology. Unlike traditional gene knockout approaches, our cell lines offer a faster turnaround time and a more reliable model for functional studies, minimizing off-target effects that may confound results.
For researchers and clinicians, investing in AP4B1 Gene Knockout Cell Lines means gaining access to a powerful tool that enhances the capabilities of molecular biology research and preclinical studies. With our extensive experience in producing high-quality biological products and our commitment to supporting scientific innovation, we provide you with the assurance of reliability and excellence in each product. Choose AP4B1 Gene Knockout Cell Lines to elevate your research and explore the complexities of genetic functions with unprecedented clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.